Century Therapeutics Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +6.0% | -9.2% | +7.3% | -4.7% | +0.6% | -2.9% | -0.6% | -2.2% | +13.5% | -15.4% | -12.9% | – | |
| – | -10.5% | -10.0% | +9.2% | -5.3% | -19.8% | -8.8% | -8.4% | -59.9% | +45.7% | +11.2% | +34.9% | – | |
| – | -123.9% | – | – | -216.3% | – | -6,463.4% | – | – | – | -303.6% | – | – | |
| – | -70.0% | -45.0% | -50.8% | +211.3% | -81.3% | +208.4% | -33.3% | -38.5% | +62.6% | +84.2% | +18.8% | – | |
| – | +341.1% | -38.0% | -393.4% | – | -21.9% | -8.7% | +16.5% | -24.2% | -9.4% | -603.6% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -218.7% | – | +211.6% | -99.5% | -320.5% | – | -100.0% | – | – | +238,811.3% | -99.8% | – | |
| – | – | – | – | – | -47.5% | -212.4% | – | -118.5% | – | -277.6% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.